Skip to main content

Table 2 Summary of confidence in effect estimates and ranking of treatments

From: Evaluation of the clinical efficacy of vaginal treatment options for persistent high-risk human papillomavirus infection after excisional treatment of cervical high-grade squamous intraepithelial lesions: a systematic review and Bayesian network meta-analysis

Comparison

Nature of the evidence

Confidence rating

Reason(s) for downgrading

IFN:NT

Mixed

Moderate

Study limitationsa

IFN:BFK

Indirect

Low

Study limitationsa, Imprecisionb

IFN:BSP

Indirect

Low

Study limitationsa, Imprecisionb

IFN:LVC

Indirect

Low

Study limitationsa, Imprecisionb

IFN:PTL

Mixed

Low

Study limitationsa, Inconstantlyc

IFN:FANIFN

Mixed

Moderate

Study limitationsa

IFN:IFNBFK

Mixed

Moderate

Study limitationsa

IFN:IFNLVC

Mixed

Moderate

Study limitationsa

BFK:NT

Mixed

Moderate

Study limitationsa

BFK:BSP

Indirect

Low

Study limitationsa, Imprecisionb

BFK:LVC

Indirect

Low

Study limitationsa, Imprecisionb

BFK:PTL

Indirect

Moderate

Study limitationsa

BFK:FANIFN

Indirect

Moderate

Study limitationsa

BFK:IFNBFK

Mixed

Moderate

Study limitationsa

BFK:IFNLVC

Indirect

Moderate

Study limitationsa

BSP:NT

Mixed

Very low

Study limitationsa, Imprecisionb, Inconstantlyc

BSP:LVC

Indirect

Low

Study limitationsa, Imprecision

BSP:PTL

Indirect

Low

Study limitationsa, Imprecisionb

BSP:FANIFN

Indirect

Low

Study limitationsa, Imprecisionb

BSP:IFNBFK

Indirect

Low

Study limitationsa, Imprecisionb

BSP:IFNLVC

Indirect

Low

Study limitationsa, Imprecisionb

LVC:NT

Mixed

Low

Study limitationsa, Imprecisionb

LVC:PTL

Indirect

Moderate

Study limitationsa

LVC:FANIFN

Indirect

Moderate

Study limitationsa

LVC:IFNBFK

Indirect

Moderate

Study limitationsa

LVC:IFNLVC

Indirect

Moderate

Study limitationsa

PTL:NT

Mixed

Moderate

Study limitationsa

PTL:FANIFN

Indirect

Low

Study limitationsa, Imprecisionb

PTL:IFNBFK

Indirect

Low

Study limitationsa, Imprecisionb

PTL:IFNLVC

Indirect

Low

Study limitationsa, Imprecisionb

FANIFN:NT

Indirect

Moderate

Study limitationsa

FANIFN:IFNBFK

Indirect

Low

Study limitationsa, Imprecisionb

FANIFN:IFNLVC

Indirect

Low

Study limitationsa, Imprecisionb

IFNBFK:NT

Indirect

Moderate

Study limitationsa

IFNBFK:IFNLVC

Mixed

Very low

Study limitationsa, Imprecisionb, Inconstantlyc

IFNLVC:NT

Indirect

Moderate

Study limitationsa

Ranking of treatments

Low

Study limitationsd, Imprecisione

  1. IFN Interferon, BFK Baofukang, PTL Paiteling, BSP Bletilla striata Sanhuang Powder, LVC Lactobacilli vaginal capsules, FAN + IFN Fuanning + Interferon, IFN + LVC Interferon + Lactobacilli vaginal capsules, IFN + BFK Interferon + Baofukang, NT No treatment
  2. aDominated by evidence at high or moderate risk of bias
  3. bConfidence intervals include values favoring either treatment
  4. cPredictive intervals for treatment effect include effects that would have different interpretations (there is additionally no convincing evidence for the plausibility of the transitivity assumption)
  5. d51.6% of the information is from studies at moderate or high risk of bias
  6. eModerate level of imprecision in the analysis